NovoCure Ltd (NAS:NVCR)
$ 23.15 0.84 (3.77%) Market Cap: 2.49 Bil Enterprise Value: 2.22 Bil PE Ratio: 0 PB Ratio: 6.93 GF Score: 60/100

Q2 2021 Novocure Ltd Earnings Call Transcript

Jul 29, 2021 / 12:00PM GMT
Release Date Price: $164 (-9.85%)
Operator

Good day, ladies and gentlemen. Thank you for standing by. Welcome to the NovoCure Second Quarter 2021 Earnings Conference Call. (Operator Instructions) Please be advised that today's conference may be recorded. (Operator Instructions)

I would now like to hand the conference over to one of your speakers today, Ingrid Goldberg. Please go ahead.

Ingrid Goldberg

Good morning, everyone, and thank you for joining us to review NovoCure's second quarter 2021 performance. I'm joined on the phone by our Executive Chairman, Bill Doyle; our CEO, Asaf Danziger; and our CFO, Ashley Cordova. Other members of our executive leadership are also on the call and available for Q&A.

The slides presented today can be viewed on our website, www.novocure.com, by clicking on the link of the second quarter 2021 financial results located in the Events section on our Investor Relations page.

Before we start, I would like to remind everyone that our discussions during this conference call will

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot